Fentanyl changes risk more than the treatment menu
Illicitly manufactured fentanyl is a highly potent synthetic opioid that is commonly found in the unregulated drug supply, sometimes without the person's knowledge. Treatment addresses opioid use disorder rather than relying on a separate fentanyl-only model, while recognizing high overdose risk and possible exposure to other substances. The approved medications for opioid use disorder still apply, but high potency and an unpredictable supply increase the need for rapid access and overdose planning. A program should not delay medication while waiting for a special fentanyl-only track.
Buprenorphine initiation may need flexibility
Methadone and buprenorphine remain evidence-based first-line medications for opioid use disorder involving fentanyl, and naltrexone is another approved option after an opioid-free period. A clinician may individualize timing, dose, and setting because recent fentanyl exposure can complicate withdrawal and medication initiation for some patients. Some patients with recent fentanyl exposure report difficult or prolonged withdrawal, and clinicians may choose among standard or alternative initiation approaches. The plan should be individualized, explained clearly, and adjusted to symptoms rather than copied from an unmonitored online protocol.
Assessment should cover the whole drug supply
Care may begin with rapid access to medication, assessment of withdrawal and other substances, infectious disease screening, mental health care, counseling, peer support, and help with housing or transportation. Some clinicians use standard buprenorphine initiation while others consider alternative protocols based on symptoms, history, and clinical judgment. Ask about pills, powders, route, frequency, last use, xylazine or stimulant exposure, prior precipitated withdrawal, overdose, and other sedatives. Wounds, infections, pain, pregnancy, housing, and mental health may need treatment at the same time.
More than one naloxone dose may be needed
Any unregulated opioid can contain an unexpected amount of fentanyl, and overdose can cause slowed or stopped breathing, blue or gray lips, pinpoint pupils, and unresponsiveness. Call 911, administer naloxone, repeat doses if needed, provide rescue breathing when trained, and stay with the person because naloxone's effect may wear off. After calling 911, give naloxone, support breathing when trained, and repeat a dose if the person does not respond. Stay with the person because fentanyl exposure may outlast the first reversal and other substances can complicate the response.
Look for low-barrier medication access
Ask how quickly the program starts buprenorphine or methadone, how it manages difficult withdrawal, and whether it provides naloxone and follow-up after missed visits. Avoid programs that offer only a brief detoxification stay while refusing ongoing medication or that promise a painless, guaranteed, or instant cure. A strong program can describe same-day or rapid intake, dose adjustment, missed-visit policies, and re-entry after renewed use. Requirements that repeatedly delay medication, force unnecessary detoxification, or discharge patients for continued symptoms can increase risk.
Use every available layer of protection
Find treatment through a qualified prescriber or certified opioid treatment program and request the earliest available appointment. Until treatment is established, carry multiple naloxone doses, avoid mixing depressants, avoid using alone, and use drug-checking services where they are legal and available. Medication, naloxone, not using alone, avoiding sedative combinations, smaller test amounts, and drug checking where available address different parts of risk. None makes unregulated fentanyl safe, but combining protections can buy time while stable treatment is established.
Plan for xylazine and other unexpected contents
The unregulated supply may contain substances that do not respond to naloxone, although naloxone should still be given when opioid exposure is possible. Wounds, prolonged sedation, or unusual symptoms need medical assessment, and people should tell clinicians what they observed without fear of punishment. Rescue breathing and 911 remain essential when breathing is impaired. Drug checking can provide useful information where available, but a negative test cannot guarantee safety.